Heparin-induced	heparin-induced	O	O
thrombocytopenia	thrombocytopenia	O	S_disease
after	after	O	O
liver	liver	O	O
transplantation	transplantation	O	O
.	.	O	O

BACKGROUND	background	O	O
:	:	O	O
Unfractionated	unfractionated	O	O
heparin	heparin	S_chemical	O
sodium	sodium	S_chemical	O
(	(	O	O
UFH	ufh	O	O
)	)	O	O
or	or	O	O
low-molecular	low-molecular	O	O
weight	weight	O	O
heparin	heparin	S_chemical	O
(	(	O	O
LMWH	lmwh	O	O
)	)	O	O
is	is	O	O
used	used	O	O
in	in	O	O
anticoagulant	anticoagulant	O	O
protocols	protocols	O	O
at	at	O	O
several	several	O	O
institutions	institutions	O	O
to	to	O	O
prevent	prevent	O	O
thrombosis	thrombosis	O	S_disease
after	after	O	O
liver	liver	O	O
transplantation	transplantation	O	O
.	.	O	O

Heparin-induced	heparin-induced	O	O
thrombocytopenia	thrombocytopenia	O	S_disease
(	(	O	O
HIT	hit	O	S_disease
)	)	O	O
is	is	O	O
an	an	O	O
adverse	adverse	O	O
immune-mediated	immune-mediated	O	O
reaction	reaction	O	O
to	to	O	O
heparin	heparin	S_chemical	O
,	,	O	O
resulting	resulting	O	O
in	in	O	O
platelet	platelet	O	O
count	count	O	O
decreases	decreases	O	O
of	of	O	O
more	more	O	O
than	than	O	O
50	50	O	O
%	%	O	O
.	.	O	O

The	the	O	O
frequencies	frequencies	O	O
of	of	O	O
HIT	hit	O	S_disease
after	after	O	O
liver	liver	O	O
transplantation	transplantation	O	O
and	and	O	O
platelet	platelet	O	O
factor	factor	O	O
4/heparin-reactive	4/heparin-reactive	O	O
antibody	antibody	O	O
(	(	O	O
HIT	hit	O	S_disease
antibody	antibody	O	O
)	)	O	O
positivity	positivity	O	O
in	in	O	O
liver	liver	O	O
transplantation	transplantation	O	O
patients	patients	O	O
,	,	O	O
however	however	O	O
,	,	O	O
are	are	O	O
unknown	unknown	O	O
.	.	O	O

PATIENTS	patients	O	O
AND	and	O	O
METHODS	methods	O	O
:	:	O	O
The	the	O	O
32	32	O	O
men	men	O	O
and	and	O	O
20	20	O	O
women	women	O	O
underwent	underwent	O	O
living	living	O	O
donor	donor	O	O
liver	liver	O	O
transplantation	transplantation	O	O
.	.	O	O

We	we	O	O
started	started	O	O
LMWH	lmwh	O	O
(	(	O	O
25	25	O	O
IU/kg/h	iu/kg/h	O	O
)	)	O	O
on	on	O	O
postoperative	postoperative	O	O
day	day	O	O
(	(	O	O
POD	pod	O	O
)	)	O	O
1	1	O	O
,	,	O	O
switching	switching	O	O
to	to	O	O
UFH	ufh	O	O
(	(	O	O
5000	5000	O	O
U/d	u/d	O	O
)	)	O	O
on	on	O	O
POD	pod	O	O
2	2	O	O
or	or	O	O
3	3	O	O
.	.	O	O

The	the	O	O
dose	dose	O	O
of	of	O	O
UFH	ufh	O	O
was	was	O	O
changed	changed	O	O
according	according	O	O
to	to	O	O
the	the	O	O
activated	activated	O	O
clotting	clotting	O	O
time	time	O	O
level	level	O	O
.	.	O	O

HIT	hit	O	S_disease
antibody	antibody	O	O
levels	levels	O	O
were	were	O	O
measured	measured	O	O
the	the	O	O
day	day	O	O
before	before	O	O
surgery	surgery	O	O
and	and	O	O
on	on	O	O
POD	pod	O	O
7	7	O	O
and	and	O	O
14	14	O	O
.	.	O	O

Platelet	platelet	O	O
count	count	O	O
was	was	O	O
measured	measured	O	O
daily	daily	O	O
for	for	O	O
3	3	O	O
weeks	weeks	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
The	the	O	O
average	average	O	O
platelet	platelet	O	O
counts	counts	O	O
preoperatively	preoperatively	O	O
,	,	O	O
and	and	O	O
on	on	O	O
POD	pod	O	O
7	7	O	O
,	,	O	O
14	14	O	O
,	,	O	O
and	and	O	O
21	21	O	O
were	were	O	O
65	65	O	O
,	,	O	O
88	88	O	O
,	,	O	O
149	149	O	O
,	,	O	O
and	and	O	O
169	169	O	O
x	x	O	O
10(9)/L	10(9)/l	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

Two	two	O	O
patients	patients	O	O
developed	developed	O	O
hepatic	hepatic	O	O
artery	artery	O	O
thrombosis	thrombosis	O	S_disease
on	on	O	O
POD	pod	O	O
11	11	O	O
and	and	O	O
19	19	O	O
,	,	O	O
respectively	respectively	O	O
,	,	O	O
although	although	O	O
they	they	O	O
were	were	O	O
HIT	hit	O	S_disease
antibody-negative	antibody-negative	O	O
and	and	O	O
their	their	O	O
platelet	platelet	O	O
counts	counts	O	O
were	were	O	O
stable	stable	O	O
.	.	O	O

In	in	O	O
2	2	O	O
other	other	O	O
patients	patients	O	O
,	,	O	O
the	the	O	O
platelet	platelet	O	O
count	count	O	O
decreased	decreased	O	O
suddenly	suddenly	O	O
from	from	O	O
107	107	O	O
x	x	O	O
10(9)/L	10(9)/l	O	O
on	on	O	O
POD	pod	O	O
4	4	O	O
to	to	O	O
65	65	O	O
x	x	O	O
10(9)/L	10(9)/l	O	O
on	on	O	O
POD	pod	O	O
6	6	O	O
and	and	O	O
from	from	O	O
76	76	O	O
x	x	O	O
10(9)/L	10(9)/l	O	O
on	on	O	O
POD	pod	O	O
7	7	O	O
to	to	O	O
33	33	O	O
x	x	O	O
10(9)/L	10(9)/l	O	O
on	on	O	O
POD	pod	O	O
9	9	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

The	the	O	O
heparin-induced	heparin-induced	O	O
platelet	platelet	O	B_disease
aggregation	aggregation	O	I_disease
test	test	O	O
was	was	O	O
negative	negative	O	O
in	in	O	O
these	these	O	O
patients	patients	O	O
.	.	O	O

The	the	O	O
percentage	percentage	O	O
of	of	O	O
HIT	hit	O	S_disease
antibody-positive	antibody-positive	O	O
patients	patients	O	O
was	was	O	O
0.5	0.5	O	O
%	%	O	O
preoperatively	preoperatively	O	O
,	,	O	O
5.6	5.6	O	O
%	%	O	O
on	on	O	O
POD	pod	O	O
7	7	O	O
,	,	O	O
and	and	O	O
5.6	5.6	O	O
%	%	O	O
on	on	O	O
POD	pod	O	O
14	14	O	O
.	.	O	O

None	none	O	O
of	of	O	O
the	the	O	O
subjects/patients	subjects/patients	O	O
developed	developed	O	O
UFH-related	ufh-related	O	O
HIT	hit	O	S_disease
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
In	in	O	O
our	our	O	O
series	series	O	O
,	,	O	O
the	the	O	O
occurrence	occurrence	O	O
of	of	O	O
HIT	hit	O	S_disease
after	after	O	O
liver	liver	O	O
transplantation	transplantation	O	O
was	was	O	O
uncommon	uncommon	O	O
.	.	O	O

